Ocugen (OCGN) EPS (Weighted Average and Diluted) (2017 - 2025)
Ocugen's EPS (Weighted Average and Diluted) history spans 9 years, with the latest figure at -$0.05 for Q2 2025.
- For Q2 2025, EPS (Weighted Average and Diluted) fell 25.0% year-over-year to -$0.05; the TTM value through Dec 2025 reached -$0.05, up 99.99%, while the annual FY2024 figure was -$0.8, N/A changed from the prior year.
- EPS (Weighted Average and Diluted) reached -$0.05 in Q2 2025 per OCGN's latest filing, up from -$0.05 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.22 in Q4 2023 to a low of -$0.13 in Q2 2021.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.05, with a median of -$0.05 recorded in 2025.
- Peak YoY movement for EPS (Weighted Average and Diluted): surged 320.0% in 2023, then tumbled 54189.97% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.07 in 2021, then plummeted by 42.86% to -$0.1 in 2022, then surged by 320.0% to $0.22 in 2023, then crashed by 81.82% to $0.04 in 2024, then tumbled by 225.0% to -$0.05 in 2025.
- Per Business Quant, the three most recent readings for OCGN's EPS (Weighted Average and Diluted) are -$0.05 (Q2 2025), -$0.05 (Q1 2025), and $0.04 (Q4 2024).